Cargando…

Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia

PURPOSE: Women with diabetes and hypertension are at increased risk of pregnancy complications, including those from surgical delivery and their offspring are at risk for congenital anomalies. Thus, diabetic and hypertensive women of reproductive age are advised to use valid contraceptive methods fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekonnen, Tensae Tadesse, Woldeyohannes, Solomon Meseret, Yigzaw, Tegbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686315/
https://www.ncbi.nlm.nih.gov/pubmed/26715862
http://dx.doi.org/10.2147/IJWH.S90741
_version_ 1782406424849022976
author Mekonnen, Tensae Tadesse
Woldeyohannes, Solomon Meseret
Yigzaw, Tegbar
author_facet Mekonnen, Tensae Tadesse
Woldeyohannes, Solomon Meseret
Yigzaw, Tegbar
author_sort Mekonnen, Tensae Tadesse
collection PubMed
description PURPOSE: Women with diabetes and hypertension are at increased risk of pregnancy complications, including those from surgical delivery and their offspring are at risk for congenital anomalies. Thus, diabetic and hypertensive women of reproductive age are advised to use valid contraceptive methods for reducing unwanted pregnancy and its complications. However, contraceptive use among these segments of the population had not been previously assessed in Ethiopia. Hence, the aim of this study was to assess contraceptive use and associated factors among diabetic and hypertensive women of reproductive age on chronic follow-up care at University of Gondar and Felege Hiwot Hospitals. METHODS: Hospital-based cross-sectional study was conducted from April to May 2012 among diabetic and hypertensive women on follow-up at the chronic illness care center. The sample size calculated was 403. Structured and pretested questionnaire was used for data collection. Data were collected using interview supplemented by chart review. The data were entered using EPI info Version 2000 and analyzed using SPSS Version 16. Frequencies, proportion, and summary statistics were used to describe the study population in relation to relevant variables. Both bivariate and multivariate analyses were run to see the association of each independent variable with contraceptive practice. RESULTS: A total of 392 married women on chronic follow-up care were interviewed making the response rate of 93.3%. The contraceptive prevalence rate was found to be 53.8%. Factors such as age 25–34 years (adjusted odds ratio, AOR [95% confidence interval, CI] =3.60 [1.05–12.36]), (AOR [95% CI] =2.29 [1.15–4.53]), having middle- and high-level incomes (AOR [95% CI] =2.12 [1.19–3.77]), (AOR [95% CI] =5.03 [2.19–11.54]), receiving provider counseling (AOR [95% CI] =9.02 [4.40–18.49]), and controlled disease condition (AOR [95% CI] =4.13 [2.35–7.28]) were significantly associated with contraceptive practice. CONCLUSION: The contraceptive utilization of women on diabetes and hypertension follow-up care was found to be low. Hence, strengthening counseling and education about family planning and controlling their medical conditions would help increase the contraceptive uptake of women on chronic follow-up.
format Online
Article
Text
id pubmed-4686315
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46863152015-12-29 Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia Mekonnen, Tensae Tadesse Woldeyohannes, Solomon Meseret Yigzaw, Tegbar Int J Womens Health Original Research PURPOSE: Women with diabetes and hypertension are at increased risk of pregnancy complications, including those from surgical delivery and their offspring are at risk for congenital anomalies. Thus, diabetic and hypertensive women of reproductive age are advised to use valid contraceptive methods for reducing unwanted pregnancy and its complications. However, contraceptive use among these segments of the population had not been previously assessed in Ethiopia. Hence, the aim of this study was to assess contraceptive use and associated factors among diabetic and hypertensive women of reproductive age on chronic follow-up care at University of Gondar and Felege Hiwot Hospitals. METHODS: Hospital-based cross-sectional study was conducted from April to May 2012 among diabetic and hypertensive women on follow-up at the chronic illness care center. The sample size calculated was 403. Structured and pretested questionnaire was used for data collection. Data were collected using interview supplemented by chart review. The data were entered using EPI info Version 2000 and analyzed using SPSS Version 16. Frequencies, proportion, and summary statistics were used to describe the study population in relation to relevant variables. Both bivariate and multivariate analyses were run to see the association of each independent variable with contraceptive practice. RESULTS: A total of 392 married women on chronic follow-up care were interviewed making the response rate of 93.3%. The contraceptive prevalence rate was found to be 53.8%. Factors such as age 25–34 years (adjusted odds ratio, AOR [95% confidence interval, CI] =3.60 [1.05–12.36]), (AOR [95% CI] =2.29 [1.15–4.53]), having middle- and high-level incomes (AOR [95% CI] =2.12 [1.19–3.77]), (AOR [95% CI] =5.03 [2.19–11.54]), receiving provider counseling (AOR [95% CI] =9.02 [4.40–18.49]), and controlled disease condition (AOR [95% CI] =4.13 [2.35–7.28]) were significantly associated with contraceptive practice. CONCLUSION: The contraceptive utilization of women on diabetes and hypertension follow-up care was found to be low. Hence, strengthening counseling and education about family planning and controlling their medical conditions would help increase the contraceptive uptake of women on chronic follow-up. Dove Medical Press 2015-12-11 /pmc/articles/PMC4686315/ /pubmed/26715862 http://dx.doi.org/10.2147/IJWH.S90741 Text en © 2015 Mekonnen et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mekonnen, Tensae Tadesse
Woldeyohannes, Solomon Meseret
Yigzaw, Tegbar
Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia
title Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia
title_full Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia
title_fullStr Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia
title_full_unstemmed Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia
title_short Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia
title_sort contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686315/
https://www.ncbi.nlm.nih.gov/pubmed/26715862
http://dx.doi.org/10.2147/IJWH.S90741
work_keys_str_mv AT mekonnentensaetadesse contraceptiveuseinwomenwithhypertensionanddiabetescrosssectionalstudyinnorthwestethiopia
AT woldeyohannessolomonmeseret contraceptiveuseinwomenwithhypertensionanddiabetescrosssectionalstudyinnorthwestethiopia
AT yigzawtegbar contraceptiveuseinwomenwithhypertensionanddiabetescrosssectionalstudyinnorthwestethiopia